Keystone Bio
PrivateLast Round
Debt
Mar 11, 2022
Total Funding Raised
$5M
Company Overview
Keystone Bio operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Debt round in March 2022.
Keystone Bio is a biotherapeutics company that develops diagnostics and therapeutics for inflammation-driven diseases such as Alzheimer's and heart disease by targeting the oral pathogen Porphyromonas gingivalis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keystone Bio Comparables
Compare Keystone Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lighthouse Pharmaceuticals | 82% | |
| Denteric | 78% | |
| ProMIS Neurosciences Inc. | 64% |
For institutional investors. Book with your work email.
Keystone Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 11, 2022 | ||||
| Series A | Apr 29, 2019 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2022
Completed a debt financing round.
- Apr 29, 2019
$5M round completed.
For institutional investors. Book with your work email.
Keystone Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keystone Bio's valuation, stock price, and market status.
Is Keystone Bio a public or private company?
Keystone Bio is a private company.
What is the current stock price of Keystone Bio?
Keystone Bio is a private company, so its shares have no public market price. Caplight tracks Keystone Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keystone Bio worth (valuation)?
Valuation information for Keystone Bio is not publicly available.
Can I buy Keystone Bio stock?
Keystone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keystone Bio's last funding round?
Keystone Bio's most recent funding round was Debt on March 11, 2022.
Who are the main investors in Keystone Bio?
Investor information for Keystone Bio is not publicly disclosed.
Will Keystone Bio IPO soon?
No public IPO plans have been announced for Keystone Bio.
How can I track Keystone Bio secondary market activity?
Caplight tracks bids, offers, and trades in Keystone Bio's shares on secondary markets.